| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 88/12/31 | 100/11/23 | 張世忠 | 張世忠 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.7(Q2) | 0 | 2.47 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 1,393,462,550 | 139,346,255 | ||
| 主要經營業務 | |||
| 生物製藥研發業務中、西藥之批發、零售業醫療器材、動物用藥之批發、零售業及國際貿易業 | |||
| 公司網址 | |||
| medigen.com.tw | |||
基亞(3176) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 166,388 | 50,053 | 135.5% | 232.4% | 606,853 | 784,830 | -22.7% |
| 2023/07 | 70,651 | 54,032 | -9.9% | 30.8% | 440,465 | 734,777 | -40% |
| 2023/06 | 78,409 | 80,364 | 6.6% | -2.4% | 369,814 | 680,745 | -45.7% |
| 2023/05 | 73,534 | 61,590 | 38.2% | 19.4% | 291,405 | 600,381 | -51.5% |
| 2023/04 | 53,216 | 54,081 | -0.6% | -1.6% | 217,871 | 538,791 | -59.6% |
| 2023/03 | 53,556 | 161,596 | 4.1% | -66.8% | 164,655 | 484,710 | -66% |
| 2023/02 | 51,462 | 46,806 | -13.7% | 9.9% | 111,099 | 323,114 | -65.6% |
| 2023/01 | 59,637 | 276,308 | -8.7% | -78.4% | 59,637 | 276,308 | -78.4% |
| 2022/12 | 65,324 | 349,267 | -9.6% | -81.3% | 1,055,947 | 3,921,849 | -73.1% |
| 2022/11 | 72,276 | 1,197,292 | 9.3% | -94% | 990,623 | 3,572,582 | -72.3% |
| 2022/10 | 66,105 | 629,114 | -1.9% | -89.5% | 918,347 | 2,375,290 | -61.3% |
| 2022/09 | 67,412 | 584,795 | 34.7% | -88.5% | 852,242 | 1,746,176 | -51.2% |
| 2022/08 | 50,053 | 767,307 | -7.4% | -93.5% | 784,830 | 1,161,381 | -32.4% |
| 2022/07 | 54,032 | 33,549 | -32.8% | 61% | 734,777 | 394,074 | 86.4% |
| 2022/06 | 80,364 | 53,985 | 30.5% | 48.9% | 680,745 | 360,525 | 88.8% |
| 2022/05 | 61,590 | 56,713 | 13.9% | 8.6% | 600,381 | 306,540 | 95.8% |
| 2022/04 | 54,081 | 64,173 | -66.5% | -15.7% | 538,791 | 249,827 | 115.7% |
| 2022/03 | 161,596 | 73,490 | 245.2% | 119.9% | 484,710 | 185,654 | 161.1% |
| 2022/02 | 46,806 | 53,668 | -83.1% | -12.8% | 323,114 | 112,164 | 188.1% |
| 2022/01 | 276,308 | 58,496 | -20.9% | 372.4% | 276,308 | 58,496 | 372.4% |
| 2021/12 | 349,267 | 75,791 | -70.8% | 360.8% | 3,921,849 | 615,541 | 537.1% |
| 2021/11 | 1,197,292 | 59,017 | 90.3% | 1928.7% | 3,572,582 | 539,750 | 561.9% |
| 2021/10 | 629,114 | 55,313 | 7.6% | 1037.4% | 2,375,290 | 480,733 | 394.1% |
| 2021/09 | 584,795 | 62,297 | -23.8% | 838.7% | 1,746,176 | 425,420 | 310.5% |
| 2021/08 | 767,307 | 42,210 | 2187.1% | 1717.8% | 1,161,381 | 363,123 | 219.8% |
| 2021/07 | 33,549 | 49,546 | -37.8% | -32.3% | 394,074 | 320,913 | 22.8% |
| 2021/06 | 53,985 | 50,824 | -4.8% | 6.2% | 360,525 | 271,671 | 32.7% |
| 2021/05 | 56,713 | 30,976 | -11.6% | 83.1% | 306,540 | 220,847 | 38.8% |
| 2021/04 | 64,173 | 58,817 | -12.7% | 9.1% | 249,827 | 189,871 | 31.6% |
| 2021/03 | 73,490 | 55,119 | 36.9% | 33.3% | 185,654 | 131,054 | 41.7% |
| 2021/02 | 53,668 | 43,006 | -8.3% | 24.8% | 112,164 | 75,935 | 47.7% |
| 2021/01 | 58,496 | 32,929 | -22.8% | 77.6% | 58,496 | 32,929 | 77.6% |
| 2020/12 | 75,791 | 118,964 | 28.4% | -36.3% | 615,541 | 584,090 | 5.4% |
| 2020/11 | 59,017 | 38,391 | 6.7% | 53.7% | 539,750 | 465,126 | 16% |
| 2020/10 | 55,313 | 43,443 | -11.2% | 27.3% | 480,733 | 426,735 | 12.6% |
| 2020/09 | 62,297 | 40,144 | 47.6% | 55.2% | 425,420 | 383,292 | 11% |
泰藝(8289) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | -21.10% | -10.32% | 2020Q3 | 6.35% | -1.15% |
| 2023Q1 | -1.44% | -3.19% | 2020Q2 | 33.39% | 3.58% |
| 2022Q4 | -14.82% | -5.40% | 2020Q1 | -19.80% | -0.56% |
| 2022Q3 | -4.60% | -0.84% | 2019Q4 | -15.56% | 0.59% |
| 2022Q2 | 8.87% | 3.86% | 2019Q3 | 27.41% | 3.57% |
| 2022Q1 | -10.22% | 6.53% | 2019Q2 | 12.80% | -0.90% |
| 2021Q4 | 3.68% | 12.32% | 2019Q1 | -15.63% | -1.62% |
| 2021Q3 | 15.57% | 10.30% | 2018Q4 | -6.91% | 0.00% |
| 2021Q2 | 24.33% | 7.65% | 2018Q3 | 8.84% | 1.00% |
| 2021Q1 | 8.41% | 8.09% | 2018Q2 | 8.70% | 0.34% |
| 2020Q4 | -8.39% | 1.05% | 2018Q1 | -9.19% | 1.71% |
評論0